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OBJECTIVES: The tuberculin skin test (TST) and the QuantiFERON-TB Gold test (QFT) are used to identify 
latent tuberculosis infections (LTBIs). The aim of this study was to determine the agreement between these 
two tests among health care workers in Iran. 
METHODS: This cross-sectional study included 177 tuberculosis (TB) laboratory staff and 67 non-TB staff. 
TST indurations of 10 mm or more were considered positive. The Student’s t-test and the chi-square test were 
used to compare the mean score and proportion of variables between the TB laboratory staff and the non-TB 
laboratory staff. Kappa statistics were used to evaluate the agreement between these tests, and logistic regres-
sion was used to assess the risk factors associated with positive results for each test. 
RESULTS: The prevalence of LTBIs according to both the QFT and the TST was 17% (95% confidence inter-
val [CI], 12% to 21%) and 16% (95% CI, 11% to 21%), respectively. The agreement between the QFT and 
the TST was 77.46%, with a kappa of 0.19 (95% CI, 0.04 to 0.34). 
CONCLUSIONS: Although the prevalence of LTBI based on the QFT and the TST was not significantly dif-
ferent, the kappa statistic was low between these two tests for the detection of LTBIs. 
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INTRODUCTION 
It is estimated that one-third of the world’s population cur-
rently has a latent tuberculosis infection (LTBI) as a result of in-
fection with Mycobacterium tuberculosis [1]. It is estimated 
that approximately 10% of individuals with an LTBI may de-
velop active tuberculosis (TB) during their lifetime [2]. The time-
ly detection of LTBIs is important to prevent the development 
of active TB [3].
The tuberculin skin test (TST) is the most commonly used 
test to identify LTBIs. Although the TST is inexpensive and sim-
ple, facilitating its use, especially in developing countries, the 
validity and reliability of the TST is affected by many factors, 
including Bacillus Calmette-Guérin (BCG) vaccination, infec-
tion with non-TB Mycobacterium (NTM) species, the method 
of TST administration, the interpretation of the reaction, insuffi-
cient dosage, and cutaneous anergy [4-7].
In recent years, the QuantiFERON-TB Gold test (QFT), which 
is one of the newly developed interferon-gamma release assays 
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(IGRAs) used to diagnose TB infections, has been used exten-
sively for the detection of latent TB [8]. The test identifies the 
level of interferon (IFN)-gamma produced in reaction to M. tu-
berculosis-specific antigens [9]. IGRAs have several important 
advantages over the TST. The most important advantage of 
IGRAs is that, unlike TST, they are not influenced by factors 
such as BCG vaccination, most NTM species, or antigen dose 
[8,10]. Nevertheless, IGRAs have some important disadvantag-
es, such as involving additional material costs and requiring a 
well-equipped laboratory and blood sampling with subsequent 
special handling to preserve the viability of lymphocytes [8]. 
However, IGRAs have a high specificity and a similar sensitivi-
ty to the TST for the detection of LTBIs [10,11].
Studies have shown poor agreement between IGRAs and the 
TST [12-14]. However, in countries with a high incidence of TB, 
an acceptable level of agreement has been reported between 
the TST and IGRA. In contrast, studies conducted in countries 
with an annual incidence of TB of ≤20 per 100,000 have found 
poor agreement between the QFT and the TST [15]. More evi-
dence is therefore needed to evaluate discrepancies in the re-
sults between IGRAs and the TST [10].
Given the lack of evidence regarding instances of disagree-
ment between the TST and IGRAs in the detection of LTBIs 
among health care workers (HCWs) in Iran, the aim of this study 
was to determine the agreement between these two tests among 
Iranian HCWs.
MATERIALS AND METHODS 
A proposal for this study was approved by the scientific com-
mittee of the Pasteur Institute of Iran. This cross-sectional study 
was performed between November 2013 and January 2014 in 
eight universities of the medical sciences, including Shiraz, Gole-
stan, Shahid Beheshti, Iran, Tehran, Tabriz, Kermanshah, and Is-
fahan. All of these universities contain regional reference TB lab-
oratories performing microscopic examinations, cultures, and 
drug sensitivity testing on M. tuberculosis isolates from through-
out Iran.
In this study, all TB laboratory staff (177 participants) and a 
random sample of non-TB staff (67 participants), including ad-
ministrative, finance, and service staff were included. Pregnant 
women were excluded from this study. A questionnaire was 
used to gather information regarding demographic variables, 
place and history of work, history of contact with TB patients, 
the presence of a BCG vaccination scar, and history of purified 
protein derivative skin tests.
Trained staff injected 0.1 mL (5 tuberculin units) of human 
tuberculin (Razi Vaccine and Serum Research Institute, Karaj, 
Iran) intradermally into the dorsal or volar surface of the fore-
arm. The TST response after 48 to 72 hours was read by a trained 
technician. TST reactions of ≥10 mm were considered positive, 
while reactions of <10 mm were interpreted as negative [6]. 
The QFT was performed using a blood sample. Blood sam-
ples were obtained before the TST. At least 3 mL of blood was 
obtained from each participant, and then a 1-mL blood sample 
was transferred into each of three QuantiFERON-TB Gold 
tubes (Cellestis Ltd., Victoria, Australia). Blood samples with 
test antigens were incubated for 16 to 24 hours based on the 
kit instructions. The plasma samples were harvested into new 
labeled tubes and were delivered to the Pasteur Institute of Iran 
through a 4°C cold chain. The concentration of IFN-gamma (IU/
mL) was measured using an automated enzyme-linked immu-
nosorbent assay. The results of the test were interpreted using 
software supplied by the manufacturer (Cellestis Ltd.) including 
a cut-off point for the detection of IFN-gamma.
The individuals who had positive TST or QFT results were 
visited by an expert specialist physician. Active TB was diag-
nosed based on clinical findings, such as general symptoms (in-
cluding fatigue, malaise, fever, weight loss, and anorexia) and 
chronic, productive cough with purulent sputum, in combina-
tion with a chest X-ray with radiological features consistent 
with TB disease.
The prevalence of LTBIs was estimated with 95% confidence 
intervals (CIs) using the QFT and TST. The concordance between 
these two tests was evaluated using proportion agreement and 
the kappa (κ) statistic. The κ statistic was interpreted as follows: 
κ>0.75 was considered to indicate excellent agreement, κ<0.40 
to indicate poor agreement, and κ between 0.40 and 0.75 to in-
dicate fair to good agreement [16]. 
Both the Student’s t-test and the chi-square test were used to 
compare means and proportions of variables between the TB 
laboratory staff and the non-TB laboratory staff. Logistic regres-
sion was used to identify risk factors associated with positive 
results for each test. Unadjusted and adjusted odds ratios (ORs) 
were reported to assess the effects of covariates on LTBI inci-
dence. All statistical analyses were conducted using Stata ver-
sion 11.0 (Stata Corp., College Station, TX, USA) and the re-
sults were reported with 95% CIs.
RESULTS
In this study, 244 participants, including 177 TB laboratory 
staff and 67 non-TB staff, were assessed for LTBIs using both 
the TST and QFT. The mean age of the TB lab staff and the non-
TB staff was 36.75 years (standard error [SE], 0.54) and 39.40 
years (SE, 1.15), respectively. Males comprised 60.25% (147 of 
244) of the participants (Table 1).
The total estimated prevalence of LTBIs based on the TST 
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was 16% (95% CI, 11% to 21%). The prevalence of LTBIs based 
on the TST among males was significantly higher than among 
females (p<0.05). Additionally, the prevalence of LTBIs based 
on this test increased with age, as subjects ≥50 years old had a 
higher prevalence of LTBIs (p<0.05) (Table 2).
Logistic regression analysis showed the adjusted OR for TB 
lab staff in comparison to non-TB staff to be 0.31 (95% CI, 
0.11 to 0.93). The adjusted OR for participants who had a his-
tory of contact with TB patients was 1.70 (95% CI, 0.71 to 4.05), 
and positive TST results among participants with a history of 
BCG vaccination were more common than among those with 
no such history (OR, 2.23; 95% CI, 0.67 to 7.43) (Table 3).
The difference in the prevalence of LTBIs measured using the 
QFT was not statistically significant across any subgroups. The 
total estimated prevalence of LTBIs based on the QFT was 17% 
(95% CI, 12% to 21%). The prevalence of LTBIs among TB lab 
staff and non-TB staff was 19% (95% CI, 12% to 24%) and 
13% (95% CI, 5% to 23%), respectively (Table 2).
According to the adjusted logistic regression, subjects with a 
history of work of 20 years or more were more likely to have 
positive QFT results than subjects with a history of work of 
zero to four years (OR, 2.64; 95% CI, 0.53 to 13.09). Partici-
pants with a history of BCG vaccination were less likely to be 
QFT-positive than others (OR, 0.50; 95% CI, 0.21 to 1.23) (Ta-
ble 3).
The overall agreement and κ statistic were 77.46% and 0.19 
(95% CI, 0.04 to 0.34), respectively. Both the TST and QFT were 
positive in 13 and negative in 176 subjects (Table 4). 
DISCUSSION
The results of this study showed that the estimated prevalence 
of LTBIs according to the QFT and the TST was 17% and 16%, 
respectively. The estimated value of agreement between the QFT 
and the TST was 77.46%, and the κ statistic was 0.19 (95% CI, 
0.04 to 0.34).
The logistic regression analysis indicated different adjusted 
ORs associated with the QFT and the TST. The adjusted OR for 
people with ≥20 years of work history was 2.64 times the base-
line for the QFT and 0.54 times the baseline for the TST. These 
results were, however, not statistically significant due to the low 
sample size of this subgroup.
Another study among Iranian HCWs reported agreement and 
Table 1. Demographic characteristics of the participants
TB lab staff Non-TB staff
p-value Total
                n        %                  n        %
Sex 
   Male
   Female
100
77
56.50
43.50
47
20
70.15
29.85
0.05 147
97
Age (yr)
20-29 
30-39 
40-49 
≥50 
29
86
56
12
15.85
46.99
30.60
6.56
10
26
22
9
14.93
38.81
32.84
123.43
0.31 39
112
78
21
Education level
No high school diploma
High school diploma
Associate degree
BS
Master of science and above
17
13
59
74
14
9.60
7.34
33.33
41.81
7.91
12
30
8
16
1
17.91
44.78
11.94
23.88
1.49
0.001 29
43
67
90
15
Job
Lab position requiring a BS 
Technician
Service personnel in lab
Administrative staff
Finance staff
Service personnel
85
60
32
-
-
-
48.02
33.90
18.08
-
-
-
-
-
-
42
10
15
-
-
-
62.69
14.93
22.39
0.001 85
60
32
42
10
15
History of work (yr)
0-4
5-9
10-14
15-19
≥20
62
42
36
25
12
35.03
23.73
20.34
14.12
6.78
14
10
12
13
18
20.90
14.93
17.91
19.40
26.87
0.001 76
52
48
38
30
History of BCG vaccination 159 89.83 50 74.63 209
TB, tuberculosis; BS, bachelor of science; BCG, Bacillus Calmette-Guérin.
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a κ statistic of 73.8% and 0.39 between the tests, respectively 
[17]. The agreement between the two tests (TST and QFT) was 
very similar in that study and our study, but the κ statistic was 
higher in their study. This discrepancy may reflect differences in 
the study population. The prevalence of TB in different regions 
of Iran is not the same [18-21], and the κ statistic is influenced 
by the prevalence of a disease [22]. In the previous study [17], 
all subjects were HCWs in a hyper-endemic region. Although 
the overall agreement between the two tests was good, it is im-
portant to note that the measures of agreement have an impor-
tant limitation; namely, these measures do not take into account 
the possibility that agreement may occur by chance alone [16].
In another study among HCWs in France, the agreement be-
tween the QFT and the TST was weak, and the κ value was 0.11 
[23]. In a study of HCWs in Turkey, the overall agreement and 
κ statistic were 63.1% and 0.22, respectively [24]. The κ statis-
tic between the QFT and the TST was found to be 0.22 in South 
Korean HCWs [25]. Among HCWs in the US, the agreement 
and κ value between the QFT and TST were 63.2% and 0.31 
(95% CI, 0.27 to 0.35), respectively [26]. The κ value between 
the QFT and TST in these studies [17,23-26] is almost the same 
as was found in our study and indicates poor agreement be-
tween the QFT and the TST.
According to the results of a meta-analysis, the κ statistic be-
tween the QFT and TST among HCWs in countries with a high 
burden of TB (0.38) was significantly more than has been ob-
served in low-burden countries (0.21) [27]. Therefore, it might 
be concluded that the agreement of the QFT and TST in popu-
Table 2. Comparison of the prevalence of LTBIs according to the QFT and TST
Variable 
QFT
p-value
TST
p-value p-value1 
Prevalence 95% CI Prevalence 95% CI
Sex 
   Male 0.17 0.11, 0.23 0.92 0.20 0.13, 0.26 <0.05 0.46
   Female 0.18 0.10, 0.25 0.10 0.04, 0.16 0.22
Age (yr)
20-29 0.10 0.03, 0.24 0.13 0.03 0.00, 0.13 <0.05 0.16
30-39 0.17 0.10, 0.25 0.16 0.10, 0.25 0.86
40-49 0.23 0.14, 0.34 0.22 0.13, 0.33 0.85
≥50 0.05 0.00, 0.24 0.23 0.08, 0.47 0.07
Education level
No high school diploma 0.21 0.06, 0.36 0.68 0.28 0.11, 0.44 0.49 0.54
High school diploma 0.09 0.00, 0.18 0.12 0.02, 0.21 0.50
Associate degree 0.18 0.09, 0.27 0.16 0.07, 0.25 0.82
BS 0.18 0.10, 0.26 0.13 0.06, 0.20 0.54
Master of science and above 0.27 0.03, 0.50 0.20 0.01, 0.41 0.67
Job group
TB lab staff 0.19 0.12, 0.24 0.34 0.14 0.09, 0.19 0.20 0.25
Non-TB staff 0.12 0.05, 0.22 0.21 0.11, 0.31 0.39
Job
Lab position requiring a BS 0.19 0.10, 0.27 0.78 0.14 0.07, 0.22 0.58 0.54
Technician 0.17 0.07, 0.26 0.17 0.07, 0.26 0.81
Service personnel in lab 0.22 0.07, 0.37 0.09 0.01, 0.20 0.17
Administrative staff 0.14 0.04, 0.25 0.19 0.07, 0.31 0.56
Finance staff - - 0.10 0.09, 0.30 0.31
Service personnel 0.20 0.01, 0.41 0.33 0.09, 0.58 0.41
History of work (yr)
0-4 0.16 0.07, 0.24 0.42 0.11 0.03, 0.18 0.46 0.34
5-9 0.15 0.05, 0.24 0.13 0.04, 0.22 0.78
10-14 0.19 0.07, 0.30 0.21 0.09, 0.33 0.62
15-19 0.16 0.04, 0.28 0.18 0.06, 0.31 0.56
≥20 0.23 0.08, 0.38 0.22 0.08, 0.39 1.00
BCG vaccination 
No 0.26 0.11, 0.40 0.15 0.11 0.01, 0.22 0.42 0.12
Yes 0.16 0.11, 0.21 0.17 0.12, 0.22 0.79
Total 0.17 0.12, 0.21 0.16 0.11, 0.21 0.90
LBTI, latent tuberculosis infection; TST, tuberculin skin test, QFT, QuantiFERON-TB Gold test; CI, confidence interval; TB, tuberculosis; BS, bachelor of 
science; BCG, Bacillus Calmette-Guérin. 
1For the comparison of the TST and QFT in each subgroup. 
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Table 3. Results of the TST and QFT according to probable risk factors 
Variable 
QFT TST
Unadjusted p-value Adjusted p-value Unadjusted p-value Adjusted p-value
Sex 
   Female 1.00 1.00 1.00 1.00
   Male 0.96 (0.49, 1.90) 0.89 0.98 (0.46, 2.07) 0.94 2.14 (0.99, 4.61) 0.05 1.75 (0.75, 4.08) 0.20
Age 1.01 (0.97, 1.05) 0.69 0.99 (0.92, 1.06) 0.77 1.07 (1.02, 1.11) 0.003 1.07 (1.00, 1.15) 0.05
Education Level
No high school diploma 1.00 1.00 1.00 1.00
High school diploma 0.39 (0.10, 1.54) 0.15 0.43 (0.10, 1.87) 0.26 0.35 (0.10, 1.19) 0.09 0.40 (0.10, 1.58) 0.19
Associate degree 0.84 (0.28, 2.49) 0.70 0.81 (0.22, 2.95) 0.75 0.52 (0.18, 1.46) 0.21 1.27 (0.35, 4.55) 0.72
Bachelor of science 0.83 (0.29, 2.36) 0.69 0.79 (0.22, 2.80) 0.71 0.40 (0.15, 1.12) 0.8 1.02 (0.28, 3.70) 0.98
Master of science and above 1.40 (0.33, 5.97) 0.66 1.19 (0.23, 6.10) 0.84 0.66 (0.15, 2.95) 0.58 1.75 (0.30, 10.16) 0.53
Job group 
Non-lab staff 1.00 1.00 1.00 1.00
TB lab staff 1.48 (0.67, 3.28) 0.34 1.88 (0.67, 5.29) 0.23 0.62 (0.30, 1.26) 0.20 2.23 (0.11, 0.93) 0.04
History of work (yr)
0-4 1.00 1.00 1.00 1.00
5-9 0.97 (0.37, 2.57) 0.95 1.00 (0.36, 2.74) 0.99 1.32 (0.45, 3.90) 0.61 1.07 (0.35, 3.30) 0.9
10-14 1.23 (0.47, 3.18) 0.67 1.42 (0.49, 4.13) 0.52 2.24 (0.81, 6.14) 0.12 1.24 (0.41, 3.75) 0.71
15-19 1.00 (0.34, 2.90) 1.00 1.30 (0.36, 4.61) 0.69 1.92 (0.64, 5.76) 0.25 0.77 (0.21, 2.85) 0.69
≥20 1.62 (0.57, 4.62) 0.36 2.64 (0.53, 13.09) 0.24 2.58 (0.84, 7.92) 0.09 0.54 (0.11, 2.68) 0.45
Contact with TB patients
No 1.00 1.00 1.00 1.00
Yes 0.95 (0.49, 1.85) 0.87 0.73 (0.34, 1.56) 0.42 1.43 (0.72, 2.84) 0.31 1.70 (0.71, 4.05) 0.23
BCG vaccination
No 1.00 1.00 1.00 1.00
Yes 0.54 (0.23, 1.26) 0.15 0.50 (0.21, 1.23) 0.13 1.56 (0.52, 4.70) 0.43 2.23 (0.67, 7.43) 0.19
Values are presented as odds ratio (95% confidence interval).
TST, tuberculin skin test, QFT, QuantiFERON-TB Gold test; TB, tuberculosis; BCG, Bacillus Calmette-Guérin.
Table 4. Overall agreement and kappa values between the QFT and TST results
Group TST results (cut-off point of ≥10 mm)
QFT results 
Total Agreement (%) Kappa (95%CI) p-value
Negative  Positive 
TB staff Negative  128 24 152 77.40 0.18 (0.00, 0.35) 0.008
Positive 16 9 25
Total 144 33 177
Non-TB staff Negative  48 5 53 77.61 0.22 (-0.06, 0.50) 0.03
Positive 10 4 14
Total 58 9 67
BCG vaccinated Negative  150 22 172 76.92 0.16 (-0.00, 0.32) 0.01
Positive 26 10 36
Total 176 32 208
Non-BCG vaccinated Negative  25 7 32 75.00 0.18 (-0.16, 0.53) 0.11
Positive 2 2 4
Total 27 9 36
All participants Negative  176 29 205 77.46 0.19 (0.04, 0.34) 0.001
Positive 26 13 39
Total 202 33 244
QFT, QuantiFERON-TB Gold test; TST, tuberculin skin test; CI, confidence interval; TB, tuberculosis; BCG, Bacillus Calmette-Guerin.
lations with a high risk of TB infection seems to be better than 
in low-risk populations. However, in the high-risk population 
investigated in the current study, the agreement was also found 
to be poor. The differences in the κ statistic among various stud-
ies may be due to differences in the prevalence of LTBIs in vari-
ous study populations. Moreover, one of the limitations of the κ 
statistic is its dependence on prevalence; namely, the κ statistic 
is higher in populations in which the prevalence is high than in 
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populations with a lower prevalence [16]. 
One study [17] showed that a family history of TB was a po-
tential risk factor for LTBI based on the QFT (OR,7.96) and 
TST (OR, 4.91). We did not observe any analogous findings. In 
our study, the adjusted OR for contact with TB patients was 
0.73 (95% CI, 0.34 to 1.56) for the QFT and 1.70 (95% CI, 
0.71 to 4.05) for the TST. One reason for this may be the avail-
ability and use of suitable protection while working with pa-
tients and/or their sputum samples. In the patients’ family mem-
bers, contact was not found to be protective.
BCG vaccination had a non-significant protective association 
with LTBIs based on the QFT (OR, 0.50; 95% CI, 0.21 to 1.23), 
while the association of BCG vaccination with LTBI based on 
the TST was not significant (OR, 2.23; 95% CI, 0.67 to 7.43). 
This inconsistency may be due to the influence of BCG vacci-
nation on the results of the TST, since other studies have shown 
that the results of the TST were influenced by BCG vaccination 
[8,10]. In a study among HCWs in the US, a positive TST with 
a negative QFT was associated with BCG vaccination (OR, 25.1; 
95% CI, 15.5 to 40.5) [26].
This study was conducted in eight universities of medical sci-
ence in Iran. All QFT samples were sent to the Department of 
Epidemiology of the Pasteur Institute of Iran, and the tests were 
performed by a trained lab expert. The TST tests were conduct-
ed by different lab experts and technicians in the eight universi-
ties. Although we trained all lab experts and technicians in the 
method of TST testing, heterogeneity may exist in TST testing 
by multiple lab experts and technicians, so this factor may have 
affected the results of the TST test.
The prevalence of LTBIs according to both the QFT and TST 
was considerable. Although the prevalence of LTBIs based on 
the QFT and TST was not significantly different, and the overall 
agreement between both tests was good, the κ statistic was low 
between these two tests. The κ value among the non-BCG vac-
cinated group was higher than among the vaccinated group. It 
seems the use of the QFT test, due to its high cost, is only ap-
propriate in cases where the results of a TST could be affected 
by BCG vaccination or NTM species.
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